
    
      A multi-center post-market single arm prospective study of Parieteneâ„¢ DS Composite Mesh in
      subjects undergoing ventral hernia repair to confirm its clinical safety and performance in
      the short (1, 3 months), mid (12 months) and long term (24 months)

      125 male or female adults subjects will be enrolled in a minimum of 4 USA sites who are
      undergoing elective ventral hernia repair (primary or incisional)
    
  